The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Saxagliptin and Metformin Hydrochloride
Saxagliptin and Metformin Hydrochloride · SAXAGLIPTIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 · Tablet, Film Coated, Extended Release · Oral · Dr.Reddys Laboratories Inc
NDC 43598-0620-30 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$9.47per unit
middle half $8.84–$11.85 · 410 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $9.47
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
7%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 94%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$339.56
Reported to Texas DSHS · 2026 annual filing · Dr. Reddy's Laboratories, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2024)
$5,256
13 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.0%chance of a new FDA shortage posting for saxagliptin and metformin hydrochloride (oral solid) in the next 90 days
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207678
- TE code
- AB
- Approval date
- Aug 9, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Saxagliptin and Metformin Hydrochloride (Tablet, Film Coated, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 2.5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 500 mg/1; METFORMIN HYDROCHLORIDE 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 1000 mg/1; METFORMIN HYDROCHLORIDE 2.5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Dr.Reddys Laboratories Inc | SAXAGLIPTIN 1000 mg/1; METFORMIN HYDROCHLORIDE 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Dr.Reddys Laboratories Inc | METFORMIN HYDROCHLORIDE 500 mg/1; SAXAGLIPTIN 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Dr.Reddys Laboratories Inc | METFORMIN HYDROCHLORIDE 1000 mg/1; SAXAGLIPTIN 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Dr.Reddys Laboratories Inc | METFORMIN HYDROCHLORIDE 1000 mg/1; SAXAGLIPTIN 2.5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Saxagliptin and Metformin Hydrochloride — NDC 43598-0620-30," retrieved September 3, 2026, https://drugdashboards.com/drug/43598062030.
Free to cite with attribution — see how the data is put together.